Association between Polymorphism of the Vitamin D Metabolism Gene CYP27B1 and HLA-B27-Associated Uveitis. Is a State of Relative Immunodeficiency Pathogenic in HLA B27-Positive Uveitis?

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Steinwender, Gernot ^a   Lindner, Ewald ^b   Weger, Martin ^a   Plainer, Sophie ^b   Renner, Wilfried ^c   Ardjomand, Navid ^a   El Shabrawi, Yosuf ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b Klinikum Klagenfurt   (Austria)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; GUANOSINE;

ADULT; ALLELE; ANKYLOSING SPONDYLITIS; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; CYP27B1 GENE; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENETIC CORRELATION; GENETIC POLYMORPHISM; GENOTYPE; HETEROZYGOSITY; HLA B27 GENE; HUMAN; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PSORIATIC ARTHRITIS; REACTIVE ARTHRITIS; RETROSPECTIVE STUDY; SPONDYLARTHRITIS; UVEITIS; VITAMIN D METABOLISM;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; ADULT; CASE-CONTROL STUDIES; DEMOGRAPHY; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HLA-B27 ANTIGEN; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; UVEITIS; VITAMIN D;

EID: 84876246702     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062244     Document Type: Article

References (32)

1. Chang JH, Wakefield D, (2002) Uveitis: A global perspective. Ocul Immunol Inflamm 10: 263-279.
2. Wakefield D, Chang JH, (2005) Epidemiology of uveitis. Int Ophthalmol Clin 45: 1-13.
3. Chang JH, McCluskey PJ, Wakefield D, (2005) Acute anterior uveitis and HLA-B27. Surv Ophthalmol 50: 364-388.
4. Suhler EB, Martin TM, Rosenbaum JT, (2003) HLA-B27-associated uveitis: Overview and current perspectives. Curr Opin Ophthalmol 14: 378-383.
5. Linssen A, Rothova A, Valkenburg HA, Dekker-Saeys AJ, Luyendijk L, et al. (1991) The lifetime cumulative incidence of acute anterior uveitis in a normal population and its relation to ankylosing spondylitis and histocompatibility antigen HLA-B27. Invest Ophthalmol Vis Sci 32: 2568-2578.
6. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, et al. (1973) Ankylosing spondylitis and HL-A 27. Lancet 1: 904-907.
7. van der Linden SM, Valkenburg HA, de Jongh BM, Cats A, (1984) The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 27: 241-249.
8. Martin TM, Rosenbaum JT, (2011) An update on the genetics of HLA B27-associated acute anterior uveitis. Ocul Immunol Inflamm 19: 108-114.
9. Dougados M, Baeten D, (2011) Spondyloarthritis. Lancet 377: 2127-2137.
10. Saarinen M, Ekman P, Ikeda M, Virtala M, Gronberg A, et al. (2002) Invasion of salmonella into human intestinal epithelial cells is modulated by HLA-B27. Rheumatology (Oxford) 41: 651-657.
11. Laitio P, Virtala M, Salmi M, Pelliniemi LJ, Yu DT, et al. (1997) HLA-B27 modulates intracellular survival of salmonella enteritidis in human monocytic cells. Eur J Immunol 27: 1331-1338.
12. Virtala M, Kirveskari J, Granfors K, (1997) HLA-B27 modulates the survival of salmonella enteritidis in transfected L cells, possibly by impaired nitric oxide production. Infect Immun 65: 4236-4242.
13. Falgarone G, Blanchard HS, Riot B, Simonet M, Breban M, (1999) Cytotoxic T-cell-mediated response against yersinia pseudotuberculosis in HLA-B27 transgenic rat. Infect Immun 67: 3773-3779.
14. Pelajo CF, Lopez-Benitez JM, Miller LC, (2010) Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 9: 507-510.
15. Maruotti N, Cantatore FP, (2010) Vitamin D and the immune system. J Rheumatol 37: 491-495.
16. Arnson Y, Amital H, Shoenfeld Y, (2007) Vitamin D and autoimmunity: New aetiological and therapeutic considerations. Ann Rheum Dis 66: 1137-1142.
17. Bailey R, Cooper JD, Zeitels L, Smyth DJ, Yang JH, et al. (2007) Association of the vitamin D metabolism gene CYP27B1 with type 1 diabetes. Diabetes 56: 2616-2621.
18. Lopez ER, Regulla K, Pani MA, Krause M, Usadel KH, et al. (2004) CYP27B1 polymorphisms variants are associated with type 1 diabetes mellitus in germans. J Steroid Biochem Mol Biol 89-90: 155-157.
19. Lopez ER, Zwermann O, Segni M, Meyer G, Reincke M, et al. (2004) A promoter polymorphism of the CYP27B1 gene is associated with addison's disease, hashimoto's thyroiditis, graves' disease and type 1 diabetes mellitus in germans. Eur J Endocrinol 151: 193-197.
20. Australia and New Zealand Multiple Sclerosis Genetics Consortium (ANZgene) (2009) Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat Genet 41: 824-828.
21. Sundqvist E, Baarnhielm M, Alfredsson L, Hillert J, Olsson T, et al. (2010) Confirmation of association between multiple sclerosis and CYP27B1. Eur J Hum Genet 18: 1349-1352.
22. Hewison M. (2010) Vitamin D and the immune system: New perspectives on an old theme. Endocrinol Metab Clin North Am 39: 365-79, table of contents.
23. Adams JS, Ren S, Liu PT, Chun RF, Lagishetty V, et al. (2009) Vitamin d-directed rheostatic regulation of monocyte antibacterial responses. J Immunol 182: 4289-4295.
24. Boonstra A, Barrat FJ, Crain C, Heath VL, Savelkoul HF, et al. (2001) 1alpha,25-dihydroxyvitamin d3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 167: 4974-4980.
25. Daniel C, Sartory NA, Zahn N, Radeke HH, Stein JM, (2008) Immune modulatory treatment of trinitrobenzene sulfonic acid colitis with calcitriol is associated with a change of a T helper (th) 1/Th17 to a Th2 and regulatory T cell profile. J Pharmacol Exp Ther 324: 23-33.
26. Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, et al. (2008) Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis. Am J Clin Nutr 88: 441-447.
27. Wegscheider BJ, Weger M, Renner W, Posch U, Ulrich S, et al. (2005) Role of the CCL2/MCP-1-2518A>G gene polymorphism in HLA-B27 associated uveitis. Mol Vis 11: 896-900.
28. El-Shabrawi Y, Wegscheider BJ, Weger M, Renner W, Posch U, et al. (2006) Polymorphisms within the tumor necrosis factor-alpha promoter region in patients with HLA-B27-associated uveitis: Association with susceptibility and clinical manifestations. Ophthalmology 113: 695-700.
29. Lindner E, Weger M, Steinwender G, Griesbacher A, Posch U, et al. (2011) IL2RA gene polymorphism rs2104286 A>G seen in multiple sclerosis is associated with intermediate uveitis: Possible parallel pathways? Invest Ophthalmol Vis Sci 52: 8295-8299.
30. Gombart AF, Borregaard N, Koeffler HP, (2005) Human cathelicidin antimicrobial peptide (CAMP) gene is a direct target of the vitamin D receptor and is strongly up-regulated in myeloid cells by 1,25-dihydroxyvitamin D3. FASEB J 19: 1067-1077.
31. Wang TT, Nestel FP, Bourdeau V, Nagai Y, Wang Q, et al. (2004) Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 173: 2909-2912.
32. Duan R, Leo P, Bradbury L, Brown MA, Thomas G, (2010) Gene expression profiling reveals a downregulation in immune-associated genes in patients with AS. Ann Rheum Dis 69: 1724-1729.